国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (19): 3288-3292.DOI: 10.3760/cma.j.cn441417-20250226-19024

• 临床研究 • 上一篇    下一篇

七叶皂苷钠对四肢骨折患者术后肢体肿胀程度及骨痂生长的影响

范小红1  梁拓1  李丽媛1  吴桂月1  李光辉2   

  1. 1河南省中医院药学部,郑州 450002;2河南省中医院骨伤科,郑州 450002

  • 收稿日期:2025-02-26 出版日期:2025-10-01 发布日期:2025-10-24
  • 通讯作者: 范小红,Email:18538503939@163.com
  • 基金资助:

    河南省中医药科学研究专项(20-21ZY2211)

Effect of sodium aesculin on limb swelling degree and callus growth in patients with limb fracture after operation

Fan Xiaohong1, Liang Tuo1, Li Liyuan1, Wu Guiyue1, Li Guanghui2   

  1. 1 Department of Pharmacy, Henan Provincial Traditional Chinese Medicine Hospital, Zhengzhou 450002, China; 2 Department of Orthopedics and Traumatology, Henan Provincial Hospital of Traditional Chinese Medicine, Zhengzhou 450002, China

  • Received:2025-02-26 Online:2025-10-01 Published:2025-10-24
  • Contact: Fan Xiaohong, Email: 18538503939@163.com
  • Supported by:

    Henan Province Chinese Medicine Scientific Research Project (20-21ZY2211)

摘要:

目的 探究七叶皂苷钠对四肢骨折患者术后肢体肿胀程度、骨痂生长的影响。方法 本研究为前瞻性研究。选取2021年1月至2024年1月在河南省中医院行手术治疗的四肢骨折患者102例,按随机数字表法分为对照组和观察组,各51例。对照组男33例,女18例,年龄(54.50±11.00)岁,骨折至就诊时间(4.25±0.48)h。观察组男30例,女21例,年龄(53.00±11.23)岁,骨折至就诊时间(4.25±0.45)h。对照组予以注射用甘露醇静脉滴注治疗,250 ml/次,1次/d。观察组予以七叶皂苷钠20 mg+500 ml生理盐水静脉滴注治疗,1次/d。两组均连续治疗1周。比较两组治疗前和治疗1周后的肢体肿胀、视觉模拟评分法(VAS)、骨痂形成评分以及炎症因子、骨代谢指标、治疗安全性。采用χ2t检验进行统计分析。结果 治疗1周后,观察组的肢体肿胀、VAS评分分别为(0.75±0.13、1.68±0.31)分,对照组分别为(0.96±0.16、2.45±0.41)分,差异均有统计学意义(t=7.275、10.698,均P<0.001);观察组的骨痂量、骨痂密度以及骨痂边缘评分分别为(3.50±0.34、3.30±0.21、3.29±0.18)分,均高于对照组的(2.86±0.30、2.71±0.18、2.75±0.15)分,差异均有统计学意义(t=10.080、15.234、16.459,均P<0.001);观察组的肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)、降钙素原(PCT)、白细胞介素-6(IL-6)水平均低于对照组,碱性磷酸酶(ALP)、骨钙素(BGP)、骨保护素(OPG)、Ⅰ型前胶原羧基端肽(PⅠCP)水平均高于对照组(均P<0.05)。两组不良反应总发生率差异无统计学意义(χ2=0.297,P=0.586)。结论 七叶皂苷钠有助于缓解四肢骨折患者术后肢体肿胀,促进骨痂生长,调节炎症因子及骨代谢水平,且安全性较高。

关键词:

四肢, 骨折, 七叶皂苷钠, 肢体肿胀, 骨痂生长

Abstract:

Objective To investigate the effects of sodium aesculin on limb swelling and callus growth in patients with limb fracture after operation. Methods This study is a prospective analysis. A total of 102 patients who underwent surgical treatment for limb fractures at Henan Provincial Hospital from January 2021 to January 2024 were selected and randomly divided into a control group and an observation group, with 51 cases in each group. The control group consisted of 33 males and 18 females, with an average age of (54.50±11.00) years and a time from fracture to treatment of (4.25±0.48) hours. The observation group included 30 males and 21 females, with an average age of (53.00±11.23) years and a time from fracture to treatment of (4.25±0.45) hours. The control group received intravenous infusion of mannitol at 250 ml per dose, once daily. The observation group received intravenous infusion of sodium aesculin 20 mg + 500 ml sodium chloride solution, once daily. Both groups were treated continuously for one week. Limb swelling, visual analog scale (VAS) scores, callus formation scores, inflammatory factors, bone metabolism indicators, and treatment safety were compared before and after one week of treatment. Statistical analysis was performed using χ2 and t tests. Results After one week of treatment, limb swelling and VAS scores in the observation group were (0.75±0.13, 1.68±0.31) points, while in the control group they were (0.96±0.16, 2.45±0.41) points, with statistically significant differences (t=7.275, 10.698; both P<0.001). The callus volume, callus density, and callus margin scores in the observation group were (3.50±0.34, 3.30±0.21, 3.29±0.18) points, all higher than those in the control group [(2.86±0.30, 2.71±0.18, 2.75±0.15) points], with statistically significant differences (t=10.080, 15.234, 16.459; all P<0.001). Levels of tumor necrosis factor-alpha (TNF-α), C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6) in the observation group were lower than those in the control group, while alkaline phosphatase (ALP), bone gamma-carboxyglutamic acid-containing protein (BGP), osteoprotegerin (OPG), and carboxy terminal peptide of type Ⅰ procollagen(PⅠCP) levels were higher in the observation group than in the control group (all P<0.05). There was no statistically significant difference in the overall incidence of adverse reactions between the two groups (χ2=0.297, P=0.586). Conclusion Sodium aesculin is safe in alleviating limb swelling, promoting callus growth, regulating inflammatory factors and bone metabolism in patients with limb fracture.

Key words:

Limbs, Fracture, Sodium aesculin, Limb swelling, Bone callus growth